Cibi e Bevande
Milestone Tasting of Cultured Meat in Europe
While the market for cultured meat is still in the early stages of development, it is foreseen to grow exponentially in the next few years and decades; A report by
McKinsey predicts that the market for cultured meat could reach
$25 billion by 2030.
To become climate relevant and meet demand, cultured meat producers will have to scale-up production fast. This is where comes in, an innovator in developing a range of animal growth factors, based on its extensive work with bioengineering barley grain. has focused on expanding its portfolio of high-quality, animal growth factors, as well as to scale-up its production capacity to meet the needs of the cultured meat industry for a reliable supply of growth factors. Growth factors are critical components in cultured meat production.
:
Berglind Rán Ólafsdóttir, CEO of ORF Genetics,
+354 617 -2736 - Berglind.olafsdottir@orfgenetics.com
George Peppou, Co-Founder and CEO of Vow,
+61 421 525 682 - george@vowfood.com
ORF Genetics is an innovative plant biotechnology company and a pioneer in developing and manufacturing high-quality recombinant proteins in bioengineered barley plants. ORFEUS, ORF Genetics' unique expression system, uses barley grains as a vehicle for large-scale protein production. The system is highly efficient, eco-friendly and 100% GRAS plant based. This technology has allowed ORF Genetics to develop a portfolio of growth factors, including a portfolio of animal growth factors called MESOkine, specifically developed for cultivated meat production.
Established in 2019, Vow is a cultured meat company that creates better meat for meat lovers. Vow's vision is to become a house of brands which uses advanced bio-manufacturing to produce a differentiated range of food products. These products are not intended to be direct replicates of traditional meat today; rather, they are intended to be meat-based products which harness the nutrition and taste of a variety of cells and species, and which tap into the sustainability afforded through modern manufacturing and cell culture technologies.
Vow currently operates two food manufacturing and R&D facilities in Sydney, Australia , with plans for a third export-focused commercial facility in development and aims to be in multiple markets by the end of 2024.
Vow's cultured Japanese Quail cells have already been deemed safe for consumption in both Australia and New Zealand , with similar confirmation expected from Singapore imminently and more to follow soon.
Photo - https://mma.prnewswire.com/media/2339646/ORF_Genetics.jpg
Logo - https://mma.prnewswire.com/media/2339647/ORF_Genetics_Logo.jpg
Logo - https://mma.prnewswire.com/media/2339645/Vow_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/milestone-tasting-of-cultured-meat-in-europe-302060944.html